微循环学杂志
微循環學雜誌
미순배학잡지
CHINESE JOURNAL OF MICROCIRCULATION
2015年
2期
8-11
,共4页
周晓玲%潘磊%马婷婷%郭蕊%江宏%姚小燕%高志敏%王勇
週曉玲%潘磊%馬婷婷%郭蕊%江宏%姚小燕%高誌敏%王勇
주효령%반뢰%마정정%곽예%강굉%요소연%고지민%왕용
通心络%低压低氧性肺动脉高压%缺氧诱导因子-1α%大鼠
通心絡%低壓低氧性肺動脈高壓%缺氧誘導因子-1α%大鼠
통심락%저압저양성폐동맥고압%결양유도인자-1α%대서
Tongxinluo%Hypobaric and hypoxia pulmonary hypertension%Hypoxia-inducible factor-1α%Rat
目的::探讨通心络对低压低氧性肺动脉高压大鼠缺氧诱导因子-1α(HIF-1α)及相关因子的影响。方法:30只体重200-250g的 SD雄性大鼠,随机分为常压常氧对照组(对照组)、低压低氧模型组(模型组)、低压低氧+通心络干预组(通心络干预组),每组10只。采用低压低氧舱模拟海拔5000m的高原环境(大气压50kp,氧浓度10%)。模型组和通心络干预组大鼠每日入舱8h,其余时间为常压常氧环境。通心络干预组每天入舱前给予通心络1.2 g生药/kg灌胃1次,对照组于同一实验室的常压常氧环境中饲养。4周后比较各组大鼠平均肺动脉压(mPAP)、右心室(RV)肥厚指数以及血清 HIF-1α、血管内皮生长因子(VEGF)、内皮素-1(ET-1)等因子水平。结果:4周后,与对照组相比,模型组大鼠mPAP、RV 肥厚指数及 HIF-1α、VEGF、ET-1等因子水平显著升高(P<0.05)。与模型组相比,通心络干预组大鼠mPAP、RV肥厚指数及血清 HIF-1α、VEGF、ET-1等因子水平均显著降低(P<0.05),且 RV肥厚指数及血清 HIF-1α、ET-1水平与对照组水平差异无统计学意义(P>0.05)。结论:通心络可能通过降低 HIF-1α水平等干预低压低氧性肺动脉高压的发生发展。
目的::探討通心絡對低壓低氧性肺動脈高壓大鼠缺氧誘導因子-1α(HIF-1α)及相關因子的影響。方法:30隻體重200-250g的 SD雄性大鼠,隨機分為常壓常氧對照組(對照組)、低壓低氧模型組(模型組)、低壓低氧+通心絡榦預組(通心絡榦預組),每組10隻。採用低壓低氧艙模擬海拔5000m的高原環境(大氣壓50kp,氧濃度10%)。模型組和通心絡榦預組大鼠每日入艙8h,其餘時間為常壓常氧環境。通心絡榦預組每天入艙前給予通心絡1.2 g生藥/kg灌胃1次,對照組于同一實驗室的常壓常氧環境中飼養。4週後比較各組大鼠平均肺動脈壓(mPAP)、右心室(RV)肥厚指數以及血清 HIF-1α、血管內皮生長因子(VEGF)、內皮素-1(ET-1)等因子水平。結果:4週後,與對照組相比,模型組大鼠mPAP、RV 肥厚指數及 HIF-1α、VEGF、ET-1等因子水平顯著升高(P<0.05)。與模型組相比,通心絡榦預組大鼠mPAP、RV肥厚指數及血清 HIF-1α、VEGF、ET-1等因子水平均顯著降低(P<0.05),且 RV肥厚指數及血清 HIF-1α、ET-1水平與對照組水平差異無統計學意義(P>0.05)。結論:通心絡可能通過降低 HIF-1α水平等榦預低壓低氧性肺動脈高壓的髮生髮展。
목적::탐토통심락대저압저양성폐동맥고압대서결양유도인자-1α(HIF-1α)급상관인자적영향。방법:30지체중200-250g적 SD웅성대서,수궤분위상압상양대조조(대조조)、저압저양모형조(모형조)、저압저양+통심락간예조(통심락간예조),매조10지。채용저압저양창모의해발5000m적고원배경(대기압50kp,양농도10%)。모형조화통심락간예조대서매일입창8h,기여시간위상압상양배경。통심락간예조매천입창전급여통심락1.2 g생약/kg관위1차,대조조우동일실험실적상압상양배경중사양。4주후비교각조대서평균폐동맥압(mPAP)、우심실(RV)비후지수이급혈청 HIF-1α、혈관내피생장인자(VEGF)、내피소-1(ET-1)등인자수평。결과:4주후,여대조조상비,모형조대서mPAP、RV 비후지수급 HIF-1α、VEGF、ET-1등인자수평현저승고(P<0.05)。여모형조상비,통심락간예조대서mPAP、RV비후지수급혈청 HIF-1α、VEGF、ET-1등인자수평균현저강저(P<0.05),차 RV비후지수급혈청 HIF-1α、ET-1수평여대조조수평차이무통계학의의(P>0.05)。결론:통심락가능통과강저 HIF-1α수평등간예저압저양성폐동맥고압적발생발전。
Objective:To study the effect of Tongxinluo on HIF-1αin rats with hypobaric and hypoxia pulmo-nary hypertension.Method:30 male SD rats weighing 200-250g were randomly divided into three groups:control group with normal pressure and normal oxygen(control group),pulmonary hypertension group with low-pressure and low-oxygen (model group),and the group treated by Tongxinluo in low-pressure and low-oxygen condition (Tongxinluo intervention group).Each group included 10 rats.Auto-modulating hypobaric and hypoxic cabin was used to simulate 5000m high altitude environment (air pressure 50kpa,oxygen concentration 10%).Tongxinluo (1. 2g/kg crude drug)was given by gastrogavage to rats in Tongxinluo intervention group once daily.Control group were exposed to normal-pressure and normal-oxygen in the same laboratory environment.4 weeks later,the mean pulmonary arterial pressure (mPAP)and right ventricular (RV)mass index were measured.Concentrations of HIF-1α,VEGF and ET-1 in blood were detected.Results:Compared with control group,mPAP,RV mass index and thelevels of HIF-1α,VEGF,ET-1 in model group were significantly increased (P<0.05).Compared with model group,rats of Tongxinluo intervention group showed lower mPAP and RV mass index,and the levels of HIF-1α, VEGF and ET-1 decreased remarkably (P<0.05).There was no significant difference between control group and Tongxinluo intervention group in right ventricular hypertrophy index and the levels of serum HIF-1αand ET-1 (P>0.05).Conclusion:Tongxinluo may influence the occurrence and development of hypobaric and hypoxia pulmonary hypertension by downregulated the level of HIF-1α.